Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
European Journal of Cancer · 2025-05 · 220 · 115338
DOI: 10.1016/j.ejca.2025.115338 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025-05. Verfasst von Changsong Qi und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Resea…. Hauptthemen laut MEDLINE: Pyrazoles, Gastrointestinal Neoplasms, Pyrimidines, Oncogene Proteins, Fusion. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing, China. El…
- State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing, China.
- Sorbonne Université and St Antoine Hospital, Paris, France.
- Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
- Inova Schar Cancer Institute, Inova Fairfax Hospital, Fairfax, VA, USA.
- Early Drug Development Unit, Vall d´Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Förderung
- NCI NIH HHS
Zitieren
APA
Qi, C., Shen, L., Andre, T., Chung, H. C., Cannon, T. L., Garralda, E., Italiano, A., Rieke, D. T., Liu, T., Burcoveanu, D. I., Neu, N., Mussi, C. E., Xu, R. H., Hong, D. S., Drilon, A., & Berlin, J. (2025). Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer. European Journal of Cancer, 220, 115338. https://doi.org/10.1016/j.ejca.2025.115338
Vancouver
Qi C, Shen L, Andre T, Chung HC, Cannon TL, Garralda E, et al. Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer. European Journal of Cancer. 2025;220:115338. doi:10.1016/j.ejca.2025.115338
BibTeX
@article{Qi2025,
author = {Qi, Changsong and Shen, Lin and Andre, Thierry and Chung, Hyun Cheol and Cannon, Timothy L and Garralda, Elena and Italiano, Antoine and Rieke, Damian T and Liu, Tianshu and Burcoveanu, Domnita-Ileana and Neu, Natascha and Mussi, Chiara E and Xu, Rui-Hua and Hong, David S and Drilon, Alexander and Berlin, Jordan},
title = {Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer},
journal = {European Journal of Cancer},
year = {2025},
volume = {220},
pages = {115338},
doi = {10.1016/j.ejca.2025.115338}
}
EUVIMED